Abraxane, a drug made by Celgene, prolonged the lives of people by nearly two months, who suffered from advance pancreatic cancer. Researchers on Tuesday reported the results of a clinical study. This signifies an advance in the treatment of a disease known to be difficult. However, the leap was not as big as some investors and doctors had hoped it would be. One doctor said it was not what they had anticipated, but he was not involved with the trial. However, others said that any progress against... 

Besides the well-known analgesic, anti-pyretic and anti-inflammatory properties of aspirin, a new study reveals that taking aspirin may reduce the risks of pancreatic cancer. The findings of the study were presented at the 102nd Annual Conference held at the American Association for Cancer Research in Orlando, Florida during the week, April 2-6, 2011. The study analyzed the association of three common types of pain relievers namely, aspirin, acetaminophen and non-aspirin NSAIDs, and their possible... 

Signs and symptoms of pancreatic cancer are often unnoticeable until the disease appears in its later stages when the tumor becomes large. When the symptoms occur, the most common ones are upper abdominal and lower back pain that often swerve to another spot as one changes position, eight out of ten pancreatic cancer suffers will eventually experience abdominal pain; yellowing of skin and the whites of eyes (jaundice); more than 10% of weight lost due to digestive problems where the bowels do not... 

Common causes of pancreatic cancer are smoking; being elderly, over 80% of cases develop between ages 60 to 80 and the likelihood increases with age; being male, the male-to-female ratio is 1.3:1 mostly because men are more likely to smoke than women; diabetes; 1% of patients diagnosed with diabetes after the age of 50 will be diagnosed with pancreatic cancer within 3 years; chronic pancreatis due to the inflammation of the pancreas due to alcoholism or gallstones and family history of pancreatic...